The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
The tor pathway: a target for cancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Dan, H. C., Sun, M., Yang, L., Feldman, R. I., Sui, X.-M., Ou, C. C., Nellist, M., Yeung, R. S., Halley, D. J. J., Nicosia, S. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205838200 · Cited by 370
RetractedThe phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
Inoki, K., Li, Y., Zhu, T., Wu, J., & Guan, K.-L. (2002) · Nature Cell Biology · doi:10.1038/ncb839 · Cited by 3,083
Kim, D.-H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,986
A mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886
Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action
Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Hidayat, S., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
VÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650
Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J., & Cantley, L. C. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00568-3 · Cited by 1,555
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545
Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands
Schreiber, S. L. (1991) · Science · doi:10.1126/science.1702904 · Cited by 1,494 · cited 1×
“This results in activation of PI3K, which catalyses the conversion of phosphatidylinositol (4,5)-bisphosphate The role of TOR-binding proteins.”
(2000) · PubMed · Cited by 1,445
Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism
Gingras, A.-C., Gygi, S. P., Raught, B., Polakiewicz, R. D., Abraham, R. T., Hoekstra, M. F., Aebersold, R., & Sonenberg, N. (1999) · Genes & Development · doi:10.1101/gad.13.11.1422 · Cited by 1,343
Targeting the PI3K-Akt pathway in human cancer
Luo, J., Manning, B. D., & Cantley, L. C. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00248-4 · Cited by 1,290
Laughner, E., Taghavi, P., Chiles, K., Mahon, P. C., & Semenza, G. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3995-4004.2001 · Cited by 1,256
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1
Burnett, P. E., Barrow, R. K., Cohen, N. A., Snyder, S. H., & Sabatini, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1432 · Cited by 1,138
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093
Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00506-2 · Cited by 1,080
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR
Neshat, M. S., Mellinghoff, I. K., Tran, C., Stiles, B., Thomas, G., Petersen, R., Frost, P., Gibbons, J. J., Wu, H., & Sawyers, C. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171076798 · Cited by 969
Mammalian TOR: a homeostatic ATP sensor
Dennis, P. B., Jaeschke, A., Saitoh, M., Fowler, B., Kozma, S. C., & Thomas, G. (2001) · Science · doi:10.1126/science.1063518 · Cited by 962
Kim, D.-H., Sarbassov, D. D., Ali, S. M., Latek, R. R., Guntur, K. V. P., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00114-x · Cited by 961
Akt regulates growth by directly phosphorylating Tsc2
Potter, C. J., Pedraza, L. G., & Xu, T. (2002) · Nature Cell Biology · doi:10.1038/ncb840 · Cited by 959
SEHGAL, S. N., BAKER, H., & VÉZINA, C. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.727 · Cited by 947
Atkins, M. B., Hidalgo, M., Stadler, W. M., Logan, T. F., Dutcher, J. P., Hudes, G. R., Park, Y., Liou, S.-H., Marshall, B., Boni, J. P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.185 · Cited by 942
Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
Jefferies, H. B. J., Fumagalli, S., Dennis, P. B., Reinhard, C., Pearson, R. B., & Thomas, G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3693 · Cited by 934
Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins
Zhang, Y., Gao, X., Saucedo, L. J., Ru, B., Edgar, B. A., & Pan, D. (2003) · Nature Cell Biology · doi:10.1038/ncb999 · Cited by 923
Rosenwald, A., Wright, G., Wiestner, A., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Muller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 914
Nourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Hierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883
Phosphorylation of the Translational Repressor PHAS-I by the Mammalian Target of Rapamycin
Brunn, G. J., Hudson, C. C., Sekulić, A., Williams, J. M., Hosoi, H., Houghton, P. J., Lawrence, J. C., & Abraham, R. T. (1997) · Science · doi:10.1126/science.277.5322.99 · Cited by 846
Self-citationLoss of PTEN facilitates HIF-1-mediated gene expression
Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A. R., Ryan, H. E., Johnson, R. S., Jefferson, A. B., et al. (2000) · Genes & Development · doi:10.1101/gad.14.4.391 · Cited by 840
Altered PTEN Expression as a Diagnostic Marker for the Earliest Endometrial Precancers
Mutter, G. L. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.924 · Cited by 829
Tee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827
Phosphorylation and Activation of p70 s6k by PDK1
Pullen, N., Dennis, P. B., Andjelkovic, M., Dufner, A., Kozma, S. C., Hemmings, B. A., & Thomas, G. (1998) · Science · doi:10.1126/science.279.5351.707 · Cited by 826
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
Wang, X. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4370 · Cited by 796
Tang, S. J., Reis, G., Kang, H., Gingras, A.-C., Sonenberg, N., & Schuman, E. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012605299 · Cited by 734
Kato, J.-Y., Matsuoka, M., Polyak, K., Massague, J., & Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90257-7 · Cited by 720
Drosophila S6 Kinase: A Regulator of Cell Size
Montagne, J., Stewart, M. J., Stocker, H., Hafen, E., Kozma, S. C., & Thomas, G. (1999) · Science · doi:10.1126/science.285.5436.2126 · Cited by 717
Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling
Gao, X., Zhang, Y., Arrazola, P., Hino, O., Kobayashi, T., Yeung, R. S., Ru, B., & Pan, D. (2002) · Nature Cell Biology · doi:10.1038/ncb847 · Cited by 672
PHAS-I as a Link Between Mitogen-Activated Protein Kinase and Translation Initiation
Lin, T.-A., Kong, X., Haystead, T. A. J., Pause, A., Belsham, G., Sonenberg, N., & Lawrence, J. C. (1994) · Science · doi:10.1126/science.7939721 · Cited by 671
Sehgal, S. N. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00045-9 · Cited by 663
Rheb promotes cell growth as a component of the insulin/TOR signalling network
Saucedo, L. J., Gao, X., Chiarelli, D. A., Li, L., Pan, D., & Edgar, B. A. (2003) · Nature Cell Biology · doi:10.1038/ncb996 · Cited by 658
Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J., & Florini, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6653 · Cited by 646
Disruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase
Shima, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636
Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family.
Jefferies, H. B., Reinhard, C., Kozma, S. C., & Thomas, G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4441 · Cited by 623
Pietenpol, J. A., Stein, R. W., Moran, E., Yaciuk, P., Schlegel, R., Lyons, R. M., Pittelkow, M. R., Münger, K., Howley, P. M., & Moses, H. L. (1990) · Cell · doi:10.1016/0092-8674(90)90188-k · Cited by 609
The TOR signaling cascade regulates gene expression in response to nutrients
Cardenas, M. E., Cutler, N. S., Lorenz, M. C., Di Como, C. J., & Heitman, J. (1999) · Genes & Development · doi:10.1101/gad.13.24.3271 · Cited by 582
Nakamura, N., Ramaswamy, S., Vazquez, F., Signoretti, S., Loda, M., & Sellers, W. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8969-8982.2000 · Cited by 570
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/−mice
Podsypanina, K., Lee, R. T., Politis, C., Hennessy, I., Crane, A., Puc, J., Neshat, M., Wang, H., Yang, L., Gibbons, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171060098 · Cited by 569
Skorski, T., Bellacosa, A., Nieborowska‐Skorska, M., Majewski, M., Martinez, R., Choi, J. K., Trotta, R., Wlodarski, P., Perrotti, D., Chan, T. O., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6151 · Cited by 567
TOR signalling in bugs, brain and brawn
Jacinto, E., & Hall, M. N. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1018 · Cited by 565
(2001) · PubMed · Cited by 557
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
Brahams, D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90821-x · Cited by 533
Rheb is an essential regulator of S6K in controlling cell growth in Drosophila
Stocker, H., Radimerski, T., Schindelholz, B., Wittwer, F., Belawat, P., Daram, P., Breuer, S., Thomas, G., & Hafen, E. (2003) · Nature Cell Biology · doi:10.1038/ncb995 · Cited by 530
TSC2 regulates VEGF through mTOR-dependent and -independent pathways
Brugarolas, J. B., Vazquez, F., Reddy, A., Sellers, W. R., & Kaelin, W. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00187-9 · Cited by 528
Regulation of eIF-4E BP1 Phosphorylation by mTOR
Hara, K., Yonezawa, K., Kozlowski, M. T., Sugimoto, T., Andrabi, K., Weng, Q.-P., Kasuga, M., Nishimoto, I., & Avruch, J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.42.26457 · Cited by 527
Hardwick, J. S., Kuruvilla, F. G., Tong, J. K., Shamji, A. F., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14866 · Cited by 522
Potter, C. J., Huang, H., & Xu, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00333-6 · Cited by 521
TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function
Schalm, S. S., Fingar, D. C., Sabatini, D. M., & Blenis, J. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00329-4 · Cited by 520
Peterson, R. T., Desai, B. N., Hardwick, J. S., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4438 · Cited by 486
Identification of a Conserved Motif Required for mTOR Signaling
Schalm, S. S., & Blenis, J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00762-5 · Cited by 482
Arsham, A. M., Howell, J. J., & Simon, M. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212770200 · Cited by 463
Rapamycin in transplantation: A review of the evidence
Saunders, R. N., Metcalfe, M. S., & Nicholson, M. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00460.x · Cited by 461
Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice
Pende, M., Kozma, S. C., Jaquet, M., Oorschot, V., Burcelin, R., Le Marchand-Brustel, Y., Klumperman, J., Thorens, B., & Thomas, G. (2000) · Nature · doi:10.1038/35050135 · Cited by 459
Chabes, A., Georgieva, B., Domkin, V., Zhao, X., Rothstein, R., & Thelander, L. (2003) · Cell · doi:10.1016/s0092-8674(03)00075-8 · Cited by 436
Yu, K., Toral-Barza, L., Discafani, C., Zhang, W. G., Skotnicki, J., Frost, P., & Gibbons, J. J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080249 · Cited by 420
Peng, T., Golub, T. R., & Sabatini, D. M. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5575-5584.2002 · Cited by 395
Powers, T., & Walter, P. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.987 · Cited by 392
Humar, R., Kiefer, F. N., Berns, H., Resink, T. J., & Battegay, E. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0658com · Cited by 381
Proliferation, But Not Growth, Blocked by Conditional Deletion of 40 S Ribosomal Protein S6
Volarević, S., Stewart, M. J., Ledermann, B., Zilberman, F., Terracciano, L., Montini, E., Grompe, M., Kozma, S. C., & Thomas, G. (2000) · Science · doi:10.1126/science.288.5473.2045 · Cited by 373
RAPAMYCIN FOR IMMUNOSUPPRESSION IN ORGAN ALLOGRAFTING
Calne, R. Y., Lim, S., Samaan, A., Collier, D. S. J., Pollard, S. G., White, D. J. G., & Thiru, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90417-0 · Cited by 367
Wienecke, R., König, A., & DeClue, J. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.27.16409 · Cited by 356
Terada, N., Patel, H. R., Takase, K., Kohno, K., Nairn, A. C., & Gelfand, E. W. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11477 · Cited by 353
Activity of rapamycin (AY-22,989) against transplanted tumors.
ENG, C. P., SEHGAL, S. N., & VEZINA, C. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1231 · Cited by 351
Xiao, G.-H., Shoarinejad, F., Jin, F., Golemis, E. A., & Yeung, R. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6097 · Cited by 349
Molecular genetic advances in tuberous sclerosis
Cheadle, J. P., Reeve, M. P., Sampson, J. R., & Kwiatkowski, D. J. (2000) · Human Genetics · doi:10.1007/s004390000348 · Cited by 349
Hashemolhosseini, S., Nagamine, Y., Morley, S. J., Desrivières, S., Mercep, L., & Ferrari, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14424 · Cited by 342
Gera, J. F., Mellinghoff, I. K., Shi, Y., Rettig, M. B., Tran, C., Hsu, J.-H., Sawyers, C. L., & Lichtenstein, A. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309999200 · Cited by 331
Boulay, A., Zumstein-Mecker, S., Stephan, C., Beuvink, I., Zilbermann, F., Haller, R., Tobler, S., Heusser, C., O’Reilly, T., Stolz, B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-3554-2 · Cited by 318
Tang, H., Hornstein, E., Stolovich, M., Levy, G., Livingstone, M., Templeton, D., Avruch, J., & Meyuhas, O. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8671-8683.2001 · Cited by 304
Kenerson, H. L., Aicher, L. D., True, L. D., & Yeung, R. S. W. (2002) · PubMed · Cited by 290
Rapamycins: Mechanisms of Action and Cellular Resistance
Huang, S., Bjornsti, M.-A., & Houghton, P. J. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.3.360 · Cited by 287
Self-citation4E-BP1 and S6K1: translational integration sites for nutritional and hormonal information in muscle
Shah, O. J., Anthony, J. C., Kimball, S. R., & Jefferson, L. S. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e715 · Cited by 286
Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K
Kozma, S. C., & Thomas, G. (2002) · BioEssays · doi:10.1002/bies.10031 · Cited by 284
Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1
Yang, D.-Q., & Kastan, M. B. (2000) · Nature Cell Biology · doi:10.1038/35046542 · Cited by 279
Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation
Dennis, P. B., Fumagalli, S., & Thomas, G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80007-0 · Cited by 275
Mayerhofer, M., Valent, P., Sperr, W. R., Griffin, J. D., & Sillaber, C. (2002) · Blood · doi:10.1182/blood-2002-01-0109 · Cited by 273
Lieberthal, W., Fuhro, R., Andry, C. C., Rennke, H., Abernathy, V. E., Koh, J. S., Valeri, R., & Levine, J. S. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.4.f693 · Cited by 270
Rosenwald, I. B., Kaspar, R., Rousseau, D., Gehrke, L., Leboulch, P., Chen, J.-J., Schmidt, E. V., Sonenberg, N., & London, I. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21176 · Cited by 269
Activation of the RAS/Cyclic AMP Pathway Suppresses a TOR Deficiency in Yeast
Schmelzle, T., Beck, T., Martin, D. E., & Hall, M. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.338-351.2004 · Cited by 261
Dennis, P. B., Pullen, N., Kozma, S. C., & Thomas, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6242 · Cited by 248
von Manteuffel, S. R., Dennis, P. B., Pullen, N., Gingras, A.-C., Sonenberg, N., & Thomas, G. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5426 · Cited by 235
Harris, T. E., & Lawrence, J. C. (2003) · Science's STKE · doi:10.1126/stke.2122003re15 · Cited by 234
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation
Martin, K. A., Rzucidlo, E. M., Merenick, B. L., Fingar, D. C., Brown, D. J., Wagner, R. J., & Powell, R. J. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00201.2003 · Cited by 232
Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779.
Shi, Y., Gera, J., Hu, L., Hsu, J.-H., Bookstein, R., Li, W., & Lichtenstein, A. K. (2002) · PubMed · Cited by 231
Stolovich, M., Tang, H., Hornstein, E., Levy, G., Cohen, R., Bae, S. S., Birnbaum, M. J., & Meyuhas, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8101-8113.2002 · Cited by 228
Tee, A. R., Anjum, R., & Blenis, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303257200 · Cited by 217
Huang, S., Shu, L., Dilling, M. B., Easton, J., Harwood, F. C., Ichijo, H., & Houghton, P. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00180-1 · Cited by 216
Self-citationMurata, K., Wu, J., & Brautigan, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10624 · Cited by 211
Shantz, L. M., & Pegg, A. E. (1994) · PubMed · Cited by 208
Rajan, P., Panchision, D. M., Newell, L. F., & McKay, R. D. G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211021 · Cited by 207
Jaeschke, A., Hartkamp, J., Saitoh, M., Roworth, W., Nobukuni, T., Hodges, A., Sampson, J., Thomas, G., & Lamb, R. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.jcb.200206108 · Cited by 206
New antitumor substances of natural origin
Douros, J., & Suffness, M. (1981) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(81)80006-0 · Cited by 202
Kim, J. E., & Chen, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011511898 · Cited by 200
Wang, L., Fraley, C. D., Faridi, J., Kornberg, A., & Roth, R. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1534805100 · Cited by 197
Phospholipase D confers rapamycin resistance in human breast cancer cells
Chen, Y., Zheng, Y., & Foster, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206565 · Cited by 196
Amino Acids as Regulators and Components of Nonproteinogenic Pathways
Meijer, A. J. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.6.2057s · Cited by 190
Mothe‐Satney, I., Yang, D., Fadden, P., Haystead, T., & Lawrence, J. C. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3558-3567.2000 · Cited by 187
Lethality of Drosophila lacking TSC tumor suppressor function rescued by reducing dS6K signaling
Radimerski, T., Montagne, J., Hemmings-Mieszczak, M., & Thomas, G. (2002) · Genes & Development · doi:10.1101/gad.239102 · Cited by 186
Role of S6 phosphorylation and S6 kinase in cell growth
Volarević, S., & Thomas, G. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)65003-1 · Cited by 185
Interaction of RAFT1 with Gephyrin Required for Rapamycin-Sensitive Signaling
Sabatini, D. M., Barrow, R. K., Blackshaw, S., Burnett, P. E., Lai, M. M., Field, M. E., Bahr, B. A., Kirsch, J., Betz, H., & Snyder, S. H. (1999) · Science · doi:10.1126/science.284.5417.1161 · Cited by 182
The proto‐oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas
Kerekatte, V., Smiley, K., Hu, B., Smith, A., Gelder, F., & De Benedetti, A. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910640107 · Cited by 177
Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.
Peralba, J. M., deGraffenried, L. A., Friedrichs, W. E., Fulcher, L. C., Grünwald, V., Weiss, G. R., & Hidalgo, M. M. (2003) · PubMed · Cited by 175
Rosenwald, I. B., Chen, J.-J., Wang, S., Savas, L., London, I. M., & Pullman, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202563 · Cited by 174
α4 Associates with Protein Phosphatases 2A, 4, and 6
Chen, J., Peterson, R. T., & Schreiber, S. L. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8792 · Cited by 174
Barata, J. T., Cardoso, A. A., Nadler, L. M., & Boussiotis, V. A. (2001) · Blood · doi:10.1182/blood.v98.5.1524 · Cited by 173
Topisirovic, I. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg069 · Cited by 171
FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse
Hentges, K. E., Sirry, B., Gingeras, A.-C., Sarbassov, D., Sonenberg, N., Sabatini, D., & Peterson, A. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241184198 · Cited by 171
Lazaris-Karatzas, A., & Sonenberg, N. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1234 · Cited by 168
Multiple Roles of Tap42 in Mediating Rapamycin-Induced Transcriptional Changes in Yeast
Düvel, K., Santhanam, A., Garrett, S., Schneper, L., & Broach, J. R. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00228-4 · Cited by 164
Human brain tumor xenografts in nude mice as a chemotherapy model
Houchens, D. P., Ovejera, A. A., Riblet, S. M., & Slagel, D. E. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90012-3 · Cited by 163
Drenan, R. M., Liu, X., Bertram, P. G., & Zheng, X.-F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305912200 · Cited by 160
Malignant transformation by overproduction of translation initiation factor eIF4G.
Shimogori, T., Ishii, I., Kashiwagi, K., Mashiba, H., EKIMOTO, H., & Igarashi, K. (1997) · PubMed · Cited by 159
The Mammalian Target of Rapamycin Regulates C2C12 Myogenesis via a Kinase-independent Mechanism
Erbay, E., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100406200 · Cited by 158
El-Hashemite, N., Walker, V., Zhang, H., & Kwiatkowski, D. J. (2003) · PubMed · Cited by 157
Ly, C., Arechiga, A. F., Melo, J. V., Walsh, C. M., & Ong, S. T. (2003) · PubMed · Cited by 156
Woltman, A. M., van der Kooij, S. W., Coffer, P. J., Offringa, R., Daha, M. R., & van Kooten, C. (2003) · Blood · doi:10.1182/blood-2002-06-1688 · Cited by 153
Astrinidis, A., Cash, T. P., Hunter, D., Walker, C. L., Chernoff, J., & Henske, E. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205962 · Cited by 153
Identification of TOR Signaling Complexes
Abraham, R. T. (2002) · Cell · doi:10.1016/s0092-8674(02)01009-7 · Cited by 150
Ras mediates translation initiation factor 4E-induced malignant transformation.Preprint
Lazaris-Karatzas, A., Smith, M. R., Frederickson, R., Jaramillo, M., Yl, L., Kung, H. F., & Sonenberg, N. (1992) · Genes & Development · doi:10.1101/gad.6.9.1631 · Cited by 145
Lim, H.-K., Choi, Y., Park, W., Lee, T., Ryu, S. H., Kim, S. Y., Kim, J.-R., Kim, J.-H., & Baek, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303789200 · Cited by 142
CREW, J. P., Fuggle, S., Bicknell, R., Cranston, D., Benedetti, A. D., & Harris, A. L. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0894 · Cited by 138
Zhang, X., Shu, L., Hosoi, H., Murti, K. G., & Houghton, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202625200 · Cited by 132
Self-citationMothe‐Satney, I., Brunn, G. J., McMahon, L. P., Capaldo, C., Abraham, R. T., & Lawrence, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006005200 · Cited by 130
Huang, S., Liu, L. N., Hosoi, H., Dilling, M. B., Shikata, T., & Houghton, P. J. (2001) · PubMed · Cited by 130
Self-citationElevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas
Nathan, C. O., Carter, P., Liu, L., Li, B. D. �., Abreo, F. W., Tudor, A., Zimmer, S. G., & Benedetti, A. D. (1997) · Oncogene · doi:10.1038/sj.onc.1201272 · Cited by 122
Molecular Analysis of Surgical Margins in Head and Neck Squamous Cell Carcinoma Patients
Nathan, C. O., Amirghahri, N., Rice, C., Abreo, F. W., Shi, R., & Stucker, F. J. (2002) · The Laryngoscope · doi:10.1097/00005537-200212000-00003 · Cited by 119
Scott, P., Smith, K. J., Poulsom, R., Benedetti, A. D., Bicknell, R., & Harris, A. L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.356 · Cited by 117
Inui, S., Sanjo, H., Maeda, K., Yamamoto, H., Miyamoto, E., & Sakaguchi, N. (1998) · Blood · doi:10.1182/blood.v92.2.539.414k23_539_546 · Cited by 117
Graff, J. R., Boghaert, E. R., Benedetti, A. D., Tudor, D., Zimmer, C. C., Chan, S. K., & Zimmer, S. G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600221 · Cited by 114
Rinker-Schaeffer, C. W., Graff, J. R., Benedetti, A. D., Zimmer, S. G., & Rhoads, R. E. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550525 · Cited by 114
Regulation of TSC2 by 14-3-3 Binding
Li, Y., Inoki, K., Yeung, R. S. W., & Guan, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200510200 · Cited by 112
Dilling, M. B., Germain, G. S., Dudkin, L., Jayaraman, A. L., Zhang, X., Harwood, F. C., & Houghton, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110782200 · Cited by 98
Self-citationSong, K. W., Cornelius, S. C., Reiß, M., & Danielpour, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304583200 · Cited by 98
14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s).
Liu, M. Y., Cai, S., Espejo, A. B., Bedford, M. T., & Walker, C. L. (2002) · PubMed · Cited by 98
Law, B. K., Chytil, A. M., Dumont, N., Hamilton, E. G., Waltner-Law, M. E., Aakre, M. E., Covington, C. D., & Moses, H. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.23.8184-8198.2002 · Cited by 97
DeFatta, R. J., Nathan, C. O., & Benedetti, A. D. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00007 · Cited by 87
Expression of the translation initiation factor eIF4E in the polyp-cancer sequence in the colon.
Berkel, H. J., Turbat‐Herrera, E. A., Shi, R., & Benedetti, A. D. (2001) · PubMed · Cited by 87
Clinical development of mammalian target of rapamycin inhibitors
Dancey, J. E. (2002) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00051-5 · Cited by 81
Bauer, C., Brass, N., Diesinger, I., Kayser, K., Grässer, F. A., & Meese, E. U. (2001) · International Journal of Cancer · doi:10.1002/ijc.10180 · Cited by 80
Zhou, C., Gehrig, P. A., Whang, Y. E., & Boggess, J. F. (2003) · PubMed · Cited by 80
Dysregulation of phosphatidylinositol 3‐kinase and downstream effectors in human breast cancer
Salh, B. S., Marotta, A., Wagey, R. T. E., Sayed, M., & Pelech, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.10147 · Cited by 78
Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?
Wong, A. S. T., Pelech, S., Woo, M. M. M., Yim, G., Rosen, B. P., Ehlen, T. G., Leung, P. C. K., & Auersperg, N. (2001) · Oncogene · doi:10.1038/sj.onc.1204253 · Cited by 77
Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ
Nellist, M. D., Goedbloed, M., de Winter, C., Verhaaf, B., Jankie, A., Reuser, A. J. J., van den Ouweland, A. M. W., van der Sluijs, P., & Halley, D. J. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204802200 · Cited by 76
Prospective Study of Eukaryotic Initiation Factor 4E Protein Elevation and Breast Cancer Outcome
Li, B. D. �., Gruner, J. S., Abreo, F. W., et al. (2002) · Annals of Surgery · doi:10.1097/00000658-200205000-00016 · Cited by 76
Shumway, S. D., Li, Y., & Xiong, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200499200 · Cited by 74 · cited 1×
“Several studies indicate that 14-3-3 PROTEINS bind to phosphorylated forms of TSC2, providing a mechanism for rapid inactivation of the TSC complex through TSC2 degradatio”
BackgroundThimmaiah, K. N., Easton, J. B., Huang, S., Veverka, K. A., Germain, G. S., Harwood, F. C., & Houghton, P. J. (2003) · PubMed · Cited by 73
Self-citationKloeker, S., Reed, R. B., McConnell, J. L., Chang, D., Tran, K. C., Westphal, R. S., Law, B. K., Colbran, R. J., Kamoun, M., Campbell, K. S., et al. (2003) · Protein Expression and Purification · doi:10.1016/s1046-5928(03)00141-4 · Cited by 66
Rosenwald, I. B. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04171-7 · Cited by 66
Shu, L., Zhang, X., & Houghton, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112285200 · Cited by 63
Self-citationMiyagi, Y., Sugiyama, A., Asai, A., Okazaki, T., Kuchino, Y., & Kerr, S. J. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03737-h · Cited by 62
Gromov, P., Madsen, P., Tomerup, N., & Celis, J. E. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01349-0 · Cited by 60
The flat-top gene is required for the expansion and regionalization of the telencephalic primordium
Hentges, K. E., Thompson, K., & Peterson, A. S. (1999) · Development · doi:10.1242/dev.126.8.1601 · Cited by 58
Jiang, H., Coleman, J., Miskimins, R., & Miskimins, W. K. (2003) · Cancer Cell International · doi:10.1186/1475-2867-3-2 · Cited by 57
Wang, S., Lloyd, R. V., Hutzler, M., Rosenwald, I. B., Safran, M., Patwardhan, N. A., & Khan, A. A. (2001) · Thyroid · doi:10.1089/10507250152740939 · Cited by 52
Sorrells, D. L., Meschonat, C., Black, D. R., & Li, B. D. �. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5653 · Cited by 48
Involvement of the Akt/mTOR pathway on EGF‐induced cell transformation
Nomura, M., He, Z., Koyama, I., Ma, W., Miyamoto, K., & Dong, Z. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10140 · Cited by 45
The zinc finger protein GLI induces cellular sensitivity to the mTOR inhibitor rapamycin.
Louro, I. D., McKie-Bell, P., Gosnell, H., Brindley, B. C., Bucy, R. P., & Ruppert, J. M. (1999) · PubMed · Cited by 44
Haydon, M. S., Googe, J. D., Sorrells, D. S., Ghali, G. E., & Li, B. D. �. (2000) · Cancer · Cited by 41
Wang, L., Rolfe, M. J., & Proud, C. G. (2003) · Biochemical Journal · doi:10.1042/bj20030454 · Cited by 36
Constitutive activation of p70S6k in cancer cells
Kwon, H.-K., Bae, G., Yoon, J., Kim, Y. K., Lee, H.-Y., Lee, H. W., & Han, J. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976945 · Cited by 31
Modulation of the Protein Kinase Activity of mTOR
Lawrence, J. C., Lin, T. A., McMahon, L. P., & Choi, K. M. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-18930-2_12 · Cited by 30
Phin, S., Kupferwasser, D., Joseph, L. A. M., & Lee-Fruman, K. K. (2003) · Biochemical Journal · doi:10.1042/bj20021794 · Cited by 26
Tirado, Ò. M., Mateo‐Lozano, S., Sanders, S., Dettin, L. E., & Notario, V. (2003) · PubMed · Cited by 25
Cited by
Upstream and downstream of mTOR
Hay, N., & Sonenberg, N. (2004) · Genes & Development · doi:10.1101/gad.1212704 · Cited by 4,181
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
The intersection between aging and cardiovascular disease
North, B. J., & Sinclair, D. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.246876 · Cited by 1,585
Metadata
- Authors
- Bjornsti, M.-A., & Houghton, P. J.
- Venue
- Nature Reviews Cancer
- Published
- 2004-05
- Volume
- 4
- Issue
- 5
- Pages
- 335-348
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2017018900
- Cited by
- 1,314
- References
- 179
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.